Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Paumier

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Cellular Biochemistry|November 6, 2010
Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer culturesS Claus, E Aubert-Foucher, M Demoor, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2018
[Interest of image-guided radiotherapy for brain tumors and positioning control]F Legouté, L Padovani, L Claude, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 24, 2012
[Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?]D Rousseau, D Autret, S Krhili, et al.
Prenatal Diagnosis|December 17, 2008
Prenatal diagnosis of Larsen syndrome caused by a mutation in the filamin B geneN Winer, F Kyndt, A Paumier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2022
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFITK Zhou, M Renouf, G Perrocheau, et al.
Clinical and Translational Radiation Oncology|January 1, 2024
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysisC Yuste, V Passerat, G Calais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 15, 2016
[Prognostic value of the metabolically active tumour volume]A Paumier, A Marquis, P Trémolières, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 2, 2015
[Are extensive fields useful for radiotherapy of esophageal cancer?]G Peyraga, O Capitain, D Rousseau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2013
[Adjuvant treatment of keloid scars: electrons or brachytherapy?]S Yossi, S Krhili, N Mesgouez-Nebout, et al.
Pathologie-Biologie|June 10, 2008
[Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: potential use of bone morphogenetic protein-2 for cartilage cell therapy]V Salentey, S Claus, C Bougault, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Cellular Biochemistry|November 6, 2010
Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer culturesS Claus, E Aubert-Foucher, M Demoor, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2018
[Interest of image-guided radiotherapy for brain tumors and positioning control]F Legouté, L Padovani, L Claude, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 24, 2012
[Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?]D Rousseau, D Autret, S Krhili, et al.
Prenatal Diagnosis|December 17, 2008
Prenatal diagnosis of Larsen syndrome caused by a mutation in the filamin B geneN Winer, F Kyndt, A Paumier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2022
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFITK Zhou, M Renouf, G Perrocheau, et al.
Clinical and Translational Radiation Oncology|January 1, 2024
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysisC Yuste, V Passerat, G Calais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 15, 2016
[Prognostic value of the metabolically active tumour volume]A Paumier, A Marquis, P Trémolières, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 2, 2015
[Are extensive fields useful for radiotherapy of esophageal cancer?]G Peyraga, O Capitain, D Rousseau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2013
[Adjuvant treatment of keloid scars: electrons or brachytherapy?]S Yossi, S Krhili, N Mesgouez-Nebout, et al.
Pathologie-Biologie|June 10, 2008
[Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: potential use of bone morphogenetic protein-2 for cartilage cell therapy]V Salentey, S Claus, C Bougault, et al.
Pageof 5